|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Duku
|
293 |
91K |
8 |
19/04/26 |
| 19/04/26 |
ASX - By Stock
|
293
|
91K
|
8
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Duku
|
293 |
91K |
3 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
293
|
91K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Duku
|
293 |
91K |
5 |
08/04/26 |
| 08/04/26 |
ASX - By Stock
|
293
|
91K
|
5
|
|
|
ASX - By Stock
|
EBR |
Re:
Ann: Annual Report
|
|
Duku
|
35 |
9.7K |
0 |
06/04/26 |
| 06/04/26 |
ASX - By Stock
|
35
|
9.7K
|
0
|
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Duku
|
5.4K |
2.4M |
6 |
30/03/26 |
| 30/03/26 |
ASX - By Stock
|
5.4K
|
2.4M
|
6
|
|
|
ASX - By Stock
|
EBR |
Re:
Ann: Annual Report
|
|
Duku
|
35 |
9.7K |
4 |
30/03/26 |
| 30/03/26 |
ASX - By Stock
|
35
|
9.7K
|
4
|
|
|
ASX - By Stock
|
EBR |
Re:
Ann: Annual Report
|
|
Duku
|
35 |
9.7K |
0 |
28/03/26 |
| 28/03/26 |
ASX - By Stock
|
35
|
9.7K
|
0
|
|
|
ASX - By Stock
|
EBR |
Re:
Ann: Annual Report
|
|
Duku
|
35 |
9.7K |
1 |
28/03/26 |
| 28/03/26 |
ASX - By Stock
|
35
|
9.7K
|
1
|
|
|
ASX - By Stock
|
EBR |
Re:
Ann: Annual Report
|
|
Duku
|
35 |
9.7K |
4 |
27/03/26 |
| 27/03/26 |
ASX - By Stock
|
35
|
9.7K
|
4
|
|
|
ASX - By Stock
|
ROC |
Re:
Be very very quiet , I’m hunting rabbits
|
|
Duku
|
7 |
2.5K |
0 |
27/03/26 |
| 27/03/26 |
ASX - By Stock
|
7
|
2.5K
|
0
|
|
|
ASX - By Stock
|
EBR |
Re:
Ann: Quarterly Cash Flow Report
|
|
Duku
|
26 |
4.7K |
1 |
19/03/26 |
| 19/03/26 |
ASX - By Stock
|
26
|
4.7K
|
1
|
|
|
ASX - By Stock
|
4DX |
Re:
down?
|
|
Duku
|
85 |
38K |
2 |
10/03/26 |
| 10/03/26 |
ASX - By Stock
|
85
|
38K
|
2
|
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
Duku
|
1.4K |
554K |
14 |
10/03/26 |
| 10/03/26 |
ASX - By Stock
|
1.4K
|
554K
|
14
|
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Duku
|
5.4K |
2.4M |
3 |
10/03/26 |
| 10/03/26 |
ASX - By Stock
|
5.4K
|
2.4M
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2026 Half Year Financial Results Webcast
|
|
Duku
|
67 |
29K |
4 |
27/02/26 |
| 27/02/26 |
ASX - By Stock
|
67
|
29K
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2026 Half Year Financial Results Webcast
|
|
Duku
|
67 |
29K |
1 |
21/02/26 |
| 21/02/26 |
ASX - By Stock
|
67
|
29K
|
1
|
|
|
ASX - By Stock
|
CDA |
Re:
Ann: CDA Half Year Results Announcement
|
|
Duku
|
12 |
3.8K |
4 |
21/02/26 |
| 21/02/26 |
ASX - By Stock
|
12
|
3.8K
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Duku
|
21K |
9.0M |
3 |
15/02/26 |
| 15/02/26 |
ASX - By Stock
|
21K
|
9.0M
|
3
|
|
|
ASX - By Stock
|
4DX |
Re:
4DX Chart
|
|
Duku
|
1.5K |
683K |
7 |
11/02/26 |
| 11/02/26 |
ASX - By Stock
|
1.5K
|
683K
|
7
|
|
|
ASX - By Stock
|
4DX |
Re:
4DX Chart
|
|
Duku
|
1.5K |
683K |
3 |
03/02/26 |
| 03/02/26 |
ASX - By Stock
|
1.5K
|
683K
|
3
|
|
|
ASX - By Stock
|
4DX |
Re:
4DX Chart
|
|
Duku
|
1.5K |
683K |
4 |
29/01/26 |
| 29/01/26 |
ASX - By Stock
|
1.5K
|
683K
|
4
|
|
|
ASX - By Stock
|
4DX |
Re:
4DX Chart
|
|
Duku
|
1.5K |
683K |
0 |
29/01/26 |
| 29/01/26 |
ASX - By Stock
|
1.5K
|
683K
|
0
|
|
|
ASX - By Stock
|
4DX |
Re:
4DX Chart
|
|
Duku
|
1.5K |
683K |
11 |
29/01/26 |
| 29/01/26 |
ASX - By Stock
|
1.5K
|
683K
|
11
|
|
|
ASX - By Stock
|
CDA |
Re:
Ann: Trading Update
|
|
Duku
|
27 |
8.2K |
0 |
27/01/26 |
| 27/01/26 |
ASX - By Stock
|
27
|
8.2K
|
0
|
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Pre-J.P. Morgan Business Update
|
|
Duku
|
49 |
16K |
6 |
27/01/26 |
| 27/01/26 |
ASX - By Stock
|
49
|
16K
|
6
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
Duku
|
337 |
128K |
7 |
13/01/26 |
| 13/01/26 |
ASX - By Stock
|
337
|
128K
|
7
|
|
|
ASX - By Stock
|
CDA |
Re:
Ann: Trading Update
|
|
Duku
|
27 |
8.2K |
4 |
09/01/26 |
| 09/01/26 |
ASX - By Stock
|
27
|
8.2K
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Duku
|
21K |
7.7M |
3 |
08/01/26 |
| 08/01/26 |
ASX - By Stock
|
21K
|
7.7M
|
3
|
|
|
ASX - By Stock
|
PNV |
Re:
Ann: U.S. Medicare Reimbursement Proposal
|
|
Duku
|
265 |
74K |
0 |
30/12/25 |
| 30/12/25 |
ASX - By Stock
|
265
|
74K
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
Chart
|
|
Duku
|
816 |
309K |
11 |
30/12/25 |
| 30/12/25 |
ASX - By Stock
|
816
|
309K
|
11
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Cleveland Clinic adopts CTVQ
|
|
Duku
|
136 |
58K |
5 |
19/12/25 |
| 19/12/25 |
ASX - By Stock
|
136
|
58K
|
5
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical secures regulatory approval for CTVQ in Canada
|
|
Duku
|
135 |
50K |
4 |
17/12/25 |
| 17/12/25 |
ASX - By Stock
|
135
|
50K
|
4
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical secures regulatory approval for CTVQ in Canada
|
|
Duku
|
135 |
50K |
9 |
17/12/25 |
| 17/12/25 |
ASX - By Stock
|
135
|
50K
|
9
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Duku
|
21K |
7.7M |
13 |
16/12/25 |
| 16/12/25 |
ASX - By Stock
|
21K
|
7.7M
|
13
|
|
|
ASX - By Stock
|
4DX |
Re:
4DX Chart
|
|
Duku
|
1.5K |
683K |
2 |
16/12/25 |
| 16/12/25 |
ASX - By Stock
|
1.5K
|
683K
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Duku
|
21K |
7.7M |
27 |
16/12/25 |
| 16/12/25 |
ASX - By Stock
|
21K
|
7.7M
|
27
|
|
|
ASX - By Stock
|
4DX |
Re:
4DX Chart
|
|
Duku
|
1.5K |
683K |
10 |
16/12/25 |
| 16/12/25 |
ASX - By Stock
|
1.5K
|
683K
|
10
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Duku
|
21K |
9.0M |
18 |
07/12/25 |
| 07/12/25 |
ASX - By Stock
|
21K
|
9.0M
|
18
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Participation at Piper Sandler Conference
|
|
Duku
|
78 |
32K |
15 |
05/12/25 |
| 05/12/25 |
ASX - By Stock
|
78
|
32K
|
15
|
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA to Present at the Piper Sandler Healthcare Conference
|
|
Duku
|
14 |
5.2K |
1 |
05/12/25 |
| 05/12/25 |
ASX - By Stock
|
14
|
5.2K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Participation at Piper Sandler Conference
|
|
Duku
|
78 |
32K |
37 |
05/12/25 |
| 05/12/25 |
ASX - By Stock
|
78
|
32K
|
37
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Participation at Piper Sandler Conference
|
|
Duku
|
78 |
32K |
22 |
05/12/25 |
| 05/12/25 |
ASX - By Stock
|
78
|
32K
|
22
|
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Duku
|
5.4K |
2.4M |
3 |
16/11/25 |
| 16/11/25 |
ASX - By Stock
|
5.4K
|
2.4M
|
3
|
|
|
Charts
|
CSL |
Re:
CSL Chart
|
|
Duku
|
1.2K |
777K |
1 |
29/10/25 |
| 29/10/25 |
Charts
|
1.2K
|
777K
|
1
|
|
|
ASX - By Stock
|
RIO |
Re:
Financed by RT?
|
|
Duku
|
7 |
1.9K |
2 |
27/10/25 |
| 27/10/25 |
ASX - By Stock
|
7
|
1.9K
|
2
|
|
|
ASX - By Stock
|
RIO |
Re:
Why so few RIO posts here?
|
|
Duku
|
107 |
65K |
1 |
23/10/25 |
| 23/10/25 |
ASX - By Stock
|
107
|
65K
|
1
|
|
|
ASX - By Stock
|
RIO |
Re:
Why so few RIO posts here?
|
|
Duku
|
107 |
65K |
1 |
23/10/25 |
| 23/10/25 |
ASX - By Stock
|
107
|
65K
|
1
|
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Announces CEO Transition
|
|
Duku
|
103 |
22K |
3 |
17/10/25 |
| 17/10/25 |
ASX - By Stock
|
103
|
22K
|
3
|
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Duku
|
5.4K |
2.4M |
2 |
10/10/25 |
| 10/10/25 |
ASX - By Stock
|
5.4K
|
2.4M
|
2
|
|
|
ASX - By Stock
|
EBR |
Re:
Ann: FDA Approval of WiSE CRT System
|
|
Duku
|
147 |
64K |
0 |
08/10/25 |
| 08/10/25 |
ASX - By Stock
|
147
|
64K
|
0
|
|